Logo image of ALK.MI

ALKEMY SPA (ALK.MI) Stock Fundamental Analysis

BIT:ALK - Euronext Milan - IT0005314635 - Common Stock - Currency: EUR

11.95  +0.05 (+0.42%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALK. ALK was compared to 31 industry peers in the Professional Services industry. ALK may be in some trouble as it scores bad on both profitability and health. ALK has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALK had negative earnings in the past year.
ALK had a positive operating cash flow in the past year.
Of the past 5 years ALK 4 years were profitable.
ALK had a positive operating cash flow in each of the past 5 years.
ALK.MI Yearly Net Income VS EBIT VS OCF VS FCFALK.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

ALK has a Return On Assets of -14.54%. This is amonst the worse of the industry: ALK underperforms 87.10% of its industry peers.
ALK has a Return On Equity of -46.87%. This is amonst the worse of the industry: ALK underperforms 87.10% of its industry peers.
Industry RankSector Rank
ROA -14.54%
ROE -46.87%
ROIC N/A
ROA(3y)-2.01%
ROA(5y)-0.01%
ROE(3y)-8.29%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ALK.MI Yearly ROA, ROE, ROICALK.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

In the last couple of years the Operating Margin of ALK has declined.
ALK has a Gross Margin (53.53%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ALK has grown nicely.
The Profit Margin and Operating Margin are not available for ALK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.53%
OM growth 3Y-37.63%
OM growth 5Y-2.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.47%
GM growth 5Y7.25%
ALK.MI Yearly Profit, Operating, Gross MarginsALK.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

ALK does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALK has more shares outstanding
Compared to 1 year ago, ALK has a worse debt to assets ratio.
ALK.MI Yearly Shares OutstandingALK.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALK.MI Yearly Total Debt VS Total AssetsALK.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 1.76, we must say that ALK is in the distress zone and has some risk of bankruptcy.
ALK's Altman-Z score of 1.76 is on the low side compared to the rest of the industry. ALK is outperformed by 67.74% of its industry peers.
The Debt to FCF ratio of ALK is 6.79, which is on the high side as it means it would take ALK, 6.79 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.79, ALK is in line with its industry, outperforming 41.94% of the companies in the same industry.
ALK has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALK (0.44) is better than 64.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 6.79
Altman-Z 1.76
ROIC/WACCN/A
WACC6.73%
ALK.MI Yearly LT Debt VS Equity VS FCFALK.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ALK has a Current Ratio of 1.16. This is a normal value and indicates that ALK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.16, ALK is in line with its industry, outperforming 54.84% of the companies in the same industry.
A Quick Ratio of 1.16 indicates that ALK should not have too much problems paying its short term obligations.
The Quick ratio of ALK (1.16) is better than 61.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
ALK.MI Yearly Current Assets VS Current LiabilitesALK.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ALK have decreased strongly by -619.18% in the last year.
ALK shows a decrease in Revenue. In the last year, the revenue decreased by -3.60%.
Measured over the past years, ALK shows a small growth in Revenue. The Revenue has been growing by 6.61% on average per year.
EPS 1Y (TTM)-619.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-445.2%
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y6.02%
Revenue growth 5Y6.61%
Sales Q2Q%-1.68%

3.2 Future

ALK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 150.00% yearly.
ALK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.32% yearly.
EPS Next Y478.57%
EPS Next 2Y150%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.75%
Revenue Next 2Y10.32%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALK.MI Yearly Revenue VS EstimatesALK.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
ALK.MI Yearly EPS VS EstimatesALK.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALK. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 9.94, the valuation of ALK can be described as reasonable.
87.10% of the companies in the same industry are more expensive than ALK, based on the Price/Forward Earnings ratio.
ALK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.46.
Industry RankSector Rank
PE N/A
Fwd PE 9.94
ALK.MI Price Earnings VS Forward Price EarningsALK.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

ALK's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 17.51
EV/EBITDA N/A
ALK.MI Per share dataALK.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

ALK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALK's earnings are expected to grow with 150.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y150%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALKEMY SPA

BIT:ALK (6/19/2025, 7:00:00 PM)

11.95

+0.05 (+0.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.14%
Inst Owner ChangeN/A
Ins Owners19.66%
Ins Owner ChangeN/A
Market Cap69.19M
Analysts45.71
Price Target10.91 (-8.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.73%
PT rev (3m)-5.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.94
P/S 0.62
P/FCF 17.51
P/OCF 9.55
P/B 2.06
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.85
EYN/A
EPS(NY)1.2
Fwd EY10.06%
FCF(TTM)0.68
FCFY5.71%
OCF(TTM)1.25
OCFY10.47%
SpS19.26
BVpS5.81
TBVpS-2.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.54%
ROE -46.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.53%
FCFM 3.54%
ROA(3y)-2.01%
ROA(5y)-0.01%
ROE(3y)-8.29%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.45%
ROCE(5y)8.95%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-37.63%
OM growth 5Y-2.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.47%
GM growth 5Y7.25%
F-Score3
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 6.79
Debt/EBITDA N/A
Cap/Depr 74.51%
Cap/Sales 2.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.76
F-Score3
WACC6.73%
ROIC/WACCN/A
Cap/Depr(3y)64.4%
Cap/Depr(5y)58.47%
Cap/Sales(3y)2.28%
Cap/Sales(5y)1.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-619.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-445.2%
EPS Next Y478.57%
EPS Next 2Y150%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y6.02%
Revenue growth 5Y6.61%
Sales Q2Q%-1.68%
Revenue Next Year14.75%
Revenue Next 2Y10.32%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-236.16%
EBIT growth 3Y-33.87%
EBIT growth 5Y4.11%
EBIT Next Year318.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7649.02%
FCF growth 3Y11.34%
FCF growth 5Y47.84%
OCF growth 1Y196.97%
OCF growth 3Y12.54%
OCF growth 5Y44.99%